This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Inis Biotech LLC, Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet), Fundacion Articular. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Provincia de Buenos Aires, AR (2019)
- Buenos Aires, AR (2021)
Company Filing History:
2 out of 20 
1 out of 82 
1 out of 1 Years Active: 2019-2021
Title: Ricardo Alfredo Dewey: Innovator in TGF-beta Research
Introduction
Ricardo Alfredo Dewey, an esteemed inventor based in Buenos Aires, Argentina, is known for his significant contributions to biomedical research, particularly in the realm of TGF-beta receptors. With two patents under his name, Dewey has made strides in developing methods for treating complex diseases, including cancer and hepatic fibrosis.
Latest Patents
Dewey's latest patents include groundbreaking advancements centered around the TGF-beta receptor II isoform and its implications for therapeutic applications. His first patent describes an isoform of the TGF-beta receptor II that comprises a sequence of approximately 80 amino acids and notably lacks a transmembrane domain. This isoform is a TGF-β1 agonist and is defined by a specific amino acid sequence, detailed as SEQ ID No. 12. Additionally, it encompasses sequences with at least 85% identity to this sequence. His second patent outlines a fusion peptide that combines this isoform with a ligand for potential utilization in cancer treatment and the management of hepatic fibrosis. The application of an antibody binding the soluble isoform of the TGF-beta II receptor further extends the patent's innovation, providing effective in vitro methods for research and application.
Career Highlights
Throughout his career, Ricardo Dewey has collaborated with notable organizations such as Inis Biotech LLC and the National Council of Scientific and Technical Research (Consejo Nacional de Investigación Científica y Técnica). His work in these institutions showcases his commitment to advancing scientific understanding and treatment options in healthcare.
Collaborations
Dewey has had the privilege of working alongside prominent colleagues like Andrea Nancy Chisari and Benito Jorge Velasco Zamora. These collaborations reflect a shared dedication to innovation and research within the field, contributing to significant advancements in TGF-beta related therapies and other scientific inquiries.
Conclusion
In summary, Ricardo Alfredo Dewey exemplifies the spirit of innovation through his dedicated research and patent contributions in the area of TGF-beta receptor II isoforms. His efforts not only underscore the importance of collaboration within scientific communities but also highlight the potential for breakthroughs in medical treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile